Cases with sinusitis, nasal septal deviation
Conditions
Interventions
Intervention Group:Oxycodone
Control Group:Sufentanil
Sponsors
Xuanwu Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Patients scheduled for elective transnasal endoscopic surgery; 2.Patients of either sex; 3.ASA I-III; 4.Age >= 18 years; 5.Provision of signed informed consent; 6.Agreement to use a postoperative patient-controlled analgesia pump.
Exclusion criteria
Exclusion criteria: 1.Patients with opioid dependence; 2.Patients with a known allergy to any drug involved in the anesthesia protocol; 3.Patients combined with major organ dysfunction; 4.Patients with contraindications to nonsteroidal anti-inflammatory drugs; 5.Patients with poor therapeutic compliance or inability to cooperate with the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of moderate-to-severe pain within 48 hours postoperatively; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sedation scores;Duration of postoperative pain in patients;Postoperative sleep quality;The number of PCA demands within 48 hours postoperatively;The incidence of adverse events (nausea and vomiting) within 48 hours after surgery.;Patient Satisfaction;Comparison of Intraoperative Parameters; | — |
Countries
China
Contacts
Public ContactTianlong Wang
Xuanwu Hospital, Capital Medical University
Outcome results
None listed